10-Q: Balance Labs Reports Increased Net Loss in Q1 2024 Amidst Going Concern Uncertainty
Quarterly Report
Balance Labs reported a net loss of $116,943 for the first quarter of 2024, an increase from the $87,280 loss in the same period last year, while also expressing substantial doubt about its ability to continue as a going concern.
Summary
- Balance Labs, a consulting firm, reported a net loss of $116,943 for the three months ended March 31, 2024, compared to a net loss of $87,280 for the same period in 2023.
- The increased loss is primarily attributed to a $30,000 increase in the CEO's salary.
- The company's total assets were $189,363 as of March 31, 2024, down from $220,721 at the end of 2023.
- The company's total liabilities were $4,849,189 as of March 31, 2024, up from $4,763,604 at the end of 2023.
- The company has a working capital deficit of $4,659,826 and an accumulated deficit of $5,472,041 as of March 31, 2024.
- The company's cash and cash equivalents decreased from $112,809 at the end of 2023 to $75,764 as of March 31, 2024.
- The company's auditors have expressed substantial doubt about its ability to continue as a going concern.
- The company plans to seek additional capital within the next twelve months to sustain operations.
Sentiment
Score: 2
Explanation: The document expresses significant concerns about the company's financial health, including a substantial increase in net loss, a large working capital deficit, and a going concern warning from auditors. The company's reliance on related party debt and the need for a capital raise further contribute to a negative outlook.
Positives
- The company experienced an unrealized gain of $5,687 on available-for-sale securities.
- The company's professional fees decreased by 15% to $16,000 for the quarter.
Negatives
- The company's net loss increased by 34% compared to the same period last year.
- The company has a significant working capital deficit of $4,659,826.
- The company's cash reserves have decreased to $75,764.
- The company's auditors have expressed substantial doubt about its ability to continue as a going concern.
- The company has a large accumulated deficit of $5,472,041.
- The company's total assets have decreased while total liabilities have increased.
Risks
- The company's ability to continue as a going concern is in doubt due to its financial condition.
- The company may need to cease operations without additional capital.
- The company's plan to raise additional capital may not be successful.
- The company's marketing campaign may not be successful.
- The company has significant debt obligations, including related party debt, that are in default.
- The company has material weaknesses in its internal controls.
Future Outlook
The company plans to seek additional capital within the next twelve months to sustain its operations and intends to formalize relationships with subcontractors to offer turn-key business development services. The company also aims to add and service a minimum of two to three new clients between now and the end of 2024.
Management Comments
- Management plans to seek to raise additional capital within the next twelve months that is expected to sustain its operations for the next year.
- Management believes that the material weaknesses set forth above were the result of the scale of our operations and are intrinsic to our small size.
- Management believes these weaknesses did not have a material effect on our financial results and intends to take remedial actions upon receiving funding for the Company's business operations.
Industry Context
The company operates in the business development and consulting services sector, which is highly competitive. The company's financial struggles and going concern issues highlight the challenges faced by small, early-stage consulting firms, particularly those with limited resources and a lack of diversified client base.
Comparison to Industry Standards
- It is difficult to compare Balance Labs directly to industry standards due to its unique business model and small scale of operations.
- Many consulting firms, such as Accenture, Deloitte, and McKinsey, have diversified client bases and significant financial resources, which Balance Labs lacks.
- The company's negative cash flow and going concern issues are not typical for established consulting firms.
- The company's reliance on related party debt is also not a common practice among larger consulting firms.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Weaknesses | The company identified material weaknesses in its internal controls, including functional controls, lack of an audit committee, and inadequate segregation of duties. | 2024-03-31 | These weaknesses could result in a material misstatement of the financial statements. |
Legal Proceedings
- There are no material pending legal proceedings to which the company is a party.
Related Party Transactions
- The company's CEO earns $10,000 per month under a new agreement.
- The company has significant debt obligations to related parties, including convertible notes and short-term advances.
- The company has related party accounts payable and accrued expenses.
Stakeholder Impact
- Shareholders face the risk of substantial dilution if the company raises capital through equity financing.
- Employees face uncertainty about the company's future due to its going concern issues.
- Creditors, particularly related parties, face the risk of not being repaid due to the company's financial difficulties.
- Customers may be hesitant to engage with the company due to its financial instability.
Next Steps
- The company plans to seek additional capital within the next twelve months.
- The company intends to formalize relationships with subcontractors.
- The company aims to add and service a minimum of two to three new clients by the end of 2024.
Key Dates
| Date | Description |
|---|---|
| 2014-06-05 | Balance Labs, Inc. was incorporated. |
| 2016-04-01 | Company received $500,000 from Newell Trading Group for a convertible debenture. |
| 2019-10-03 | Newell Trading Group assigned its convertible debenture to the Sammy Farkas Foundation Inc. |
| 2021-01-29 | Company received 20% ownership of Pharmacy No, 27, Ltd. |
| 2021-09-30 | Balance Labs Inc. made a loan to Four Acquisition, Ltd. |
| 2023-10-31 | New agreement for CEO compensation became effective. |
| 2024-03-31 | End of the quarterly period for this report. |
| 2024-05-10 | Date of the report. |
Keywords
consulting, financial results, going concern, net loss, working capital, debt, capital raise, internal controls, related party transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.